Related Experiment Video
Updated: Jul 9, 2026

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
fMRI Insights into Visual Cortex Dysfunction as a Biomarker for Migraine with Aura
Damian Pikor1, Natalia Banaszek-Hurla1, Alicja Drelichowska1
1Laboratory of Neurobiology, Department of Neurology, Poznań University of Medical Sciences, 60-355 Poznan, Poland.
Neurology International
|February 25, 2025
Summary
Migraine with aura involves cortical spreading depression, linked to ion channel dysfunction and cortical hyperexcitability. Advanced neuroimaging and genetic studies reveal key insights into its complex pathophysiology.
Area of Science:
- Neurology
- Neuroscience
- Genetics
Background:
- Migraine with aura (MwA) is a disabling neurological disorder characterized by recurrent visual disturbances.
- The underlying pathophysiology of MwA remains incompletely understood, though cortical spreading depression (CSD) is implicated.
Purpose of the Study:
- To synthesize current knowledge on the pathophysiology of MwA.
- To analyze molecular and neurophysiological targets for developing new therapies.
Main Methods:
- Review of molecular, genetic, and neuroimaging studies, including functional magnetic resonance imaging (fMRI) and arterial spin labelling (ASL).
- Analysis of ion channel dysfunction, calcium channel gene families (e.g., CACNA), and glutamate release.
Main Results:
- CSD is a central mechanism in MwA, triggered by ion channel dysfunction and leading to cortical hyperexcitability.
- Neuroimaging reveals enduring cortical dysfunction beyond aura episodes, with specific visual cortex activation patterns potentially serving as a biomarker.
- MwA is multifactorial, influenced by cortical, vascular, and genetic factors.
Conclusions:
- Advances in molecular, genetic, and neuroimaging research have significantly improved understanding of MwA pathophysiology.
- Targeting cortical excitability and neural network stability offers a foundation for developing novel MwA therapies.
- Further research into molecular and neurophysiological targets is crucial for alleviating the burden of migraine with aura.

